Vnitr Lek 2017, 63(11):770-775 | DOI: 10.36290/vnl.2017.148

Diagnostics and treatment of community-acquired pneumonia - simplicity is the key to success

Vítězslav Kolek*, Petr Jakubec, Stanislav Losse
Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc

Pneumonia is the most wide-spread infectious disease and requires unrelenting attention. It is defined as an acute inflammatory disease affecting pulmonary alveoli, respiratory bronchioles and the pulmonary interstitium. In recent years we have seen the endeavour to rationalize the approach to pneumonias and utilize the current methods of administering effective antibiotics to reduce occurrence of complications, limit the number of hospitalizations and shorten the length of treatment. With the awareness of all the potential agents it is empiric therapy which predominates, being supported by the knowledge of a regional epidemiological situation, good diagnosing and experience of rational antibiotic treatment. Very important is categorization of patients based on possible risks of complications and mortality. Considering that an appropriate form of treatment is chosen: outpatient care or hospitalization.

Keywords: community-acquired pneumonia; treatment criteria; prognosis; occurrence

Received: August 18, 2017; Accepted: September 26, 2017; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolek V, Jakubec P, Losse S. Diagnostics and treatment of community-acquired pneumonia - simplicity is the key to success. Vnitr Lek. 2017;63(11):770-775. doi: 10.36290/vnl.2017.148.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kolek V, Kolář M, Kašák V et al. Diagnostika a léčba komunitně získané pneumonie dospělých. Vnitř Lék 2011; 57(10): 858-866. Go to PubMed...
    2. Niederman MS, McCombs JS, Unger AN et al. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20(4): 820-837. Go to original source... Go to PubMed...
    3. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the United Kingdom. Eur Respir J 1997; 10(7): 1530-1534. Go to original source... Go to PubMed...
    4. Gibson GJ, Loddenkemper R, Lundbäck B et al. Respiratory health and disease in Europe: the new European Lung White Book. Eur Respir J 2013; 42: 559-563. Dostupné z DOI: <http://dx.doi.org/10.1183/09031936.00105513>. Go to original source... Go to PubMed...
    5. File TM. Community-acquired pneumonia. Lancet 2003; 362(9400): 1991-2001. Go to original source... Go to PubMed...
    6. Barlow GD, Lamping DL, Davey PG et al. Evaluation of outcomes in community-acquired pneumonia: a guide for patients, physicians, and policy-makers. Lancet Infect Dis 2003; 3(8): 476-488. Go to original source... Go to PubMed...
    7. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect 2011; 17(Suppl 6): E1-E59. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1469-0691.2011.03672.x>. Go to original source... Go to PubMed...
    8. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2): S27-S72. Go to original source... Go to PubMed...
    9. Macfarlane JT, Boldy D. 2004 update of BTS pneumonia guidelines: What's new? Thorax 2004; 59(5): 364-366. Go to original source... Go to PubMed...
    10. Dean NC, Silver MP, Bateman KA et al. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 2001; 110(6): 451-457. Go to original source... Go to PubMed...
    11. Kolek V, Fojtů H, Grygárková I et al. Pneumonie vyžadující hospitalizaci: výsledky dvouleté multicentrické studie v České republice. Int Med Prax 2002; 4(7): 347-352.
    12. Pletz MW, Ewig S, Lange C et al. Update Pneumonie 2012. Dtsch Med Wochenschr 2012; 137(44): 2265-2284. Dostupné z DOI: <http://dx.doi.org/10.1055/s-0032-1305297>. Go to original source... Go to PubMed...
    13. de Roux A, Ewig S, García E et al. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J 2006; 27(4): 795-800. Go to original source... Go to PubMed...
    14. Gleason PP, Meehan TP, Fine JM et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159(21): 2562-2572. Go to original source... Go to PubMed...
    15. Smith SB, Ruhnke GW, Weiss CH et al. Trends in Pathogens Among Patients Hospitalized for Pneumonia From 1993 to 2011. JAMA Intern Med 2014; 174(11): 1837-1839. Dostupné z DOI: <http://dx.doi.org/10.1001/jamainternmed.2014.4344>. Go to original source... Go to PubMed...
    16. McKinnell J, Class P, Blumberg P et al. Clinical Predictors of Antibiotic Failure in Adult Outpatients with Community-Acquired Pneumonia. Am J Respir Crit Care Med 2017; 195: A2644. Dostupné z WWW: <http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A2644>.
    17. Kolek V, Bartoš V, Fojtů H et al. Studie PAP - Pneumonie v ambulantní péči. Stud Pneumol Phthiseol 2007; 67(4): 146-154.
    18. Moberley S, Holden J, Tatham DP et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013; (1): CD000422. Dostupné z DOI: <http://dx.doi.org/10.1002/14651858.CD000422.pub3>. Go to original source... Go to PubMed...
    19. Kolek V, Vágnerová I et al. Kapesní původce ambulantní léčbou respiračních infekcí. Maxdorf: Praha 2016. ISBN 978-80-7345-490-6.
    20. Ho PL, Tse WS, Tsang KWT et al. Risk factors for acquisition of Levofloxacin-resistant Streptococcus pneumoniae: A case-control study. Clin Infect Dis 2001; 32(5): 701-707. Go to original source... Go to PubMed...
    21. Waterer GW, Somes GW, Wunderrink RG. Monotherapy may be suboptimal for severe bacteraemic pneumococcal pneumonia. Arch Intern Med 2001; 161(15): 1837-1842. Go to original source... Go to PubMed...
    22. Martinez JA, Horcajada JP, Almela M et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003; 36(4): 389-395. Go to original source... Go to PubMed...
    23. Soo Hoo GW, Wen YE, Nguyen TV et al. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 2005; 128(4): 2778-2787. Go to original source... Go to PubMed...
    24. Eccles S, Pincus C, Higgins B et al. Pneumonia. Diagnosis and management of community and hospital-acquired pneumonia in adults. BMJ 2014; 349:g6722. Dostupné z DOI: <http://dx.doi.org/10.1136/bmj.g6722>. Go to original source... Go to PubMed...
    25. Ito A, Ishida T, Tokumasu H et al. Prognostic Factors in Hospitalized Community-Acquired Pneumonia. A Retrospective Study of a Prospective Observational Cohort. BMC Pulm Med 2017; 17(1): 78. Dostupné z DOI: <http://dx.doi.org/10.1186/s12890-017-0424-4>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.